Spruce Biosciences, Inc. (SPRB)
OTCMKTS
· Delayed Price · Currency is USD
0.0786
-0.0005 (-0.63%)
Apr 28, 2025, 4:00 PM EDT
Spruce Biosciences Market Cap
Spruce Biosciences has a market cap or net worth of $3.12 million as of May 2, 2025. Its market cap has decreased by -89.27% in one year.
Market Cap
3.12M
Enterprise Value
-32.87M
Revenue
4.91M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.08
Market Cap Chart
Since October 9, 2020, Spruce Biosciences's market cap has decreased from 378.48M to 3.12M, a decrease of -99.18%. That is a compound annual growth rate of -65.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 2, 2025 | 3.12M | -82.02% |
| Dec 31, 2024 | 17.35M | -85.46% |
| Dec 29, 2023 | 119.28M | 361.35% |
| Dec 30, 2022 | 25.86M | -75.29% |
| Dec 31, 2021 | 104.65M | -81.46% |
| Dec 31, 2020 | 564.33M | 49.10% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Endo Inc. | 1.62B |
| Nika Pharmaceuticals | 1.02B |
| Veradigm | 746.57M |
| Tian'an Technology Group | 546.22M |
| Glass House Brands | 529.49M |
| Elite Pharmaceuticals | 452.95M |
| Northwest Biotherapeutics | 429.16M |
| CytoDyn | 401.57M |